Company Overview of Gryphon Therapeutics, Inc.
Gryphon Therapeutics, Inc. went out of business. Gryphon Therapeutics, Inc. develops polymer-modified proteins made by chemical synthesis. Its products combine chemically synthesized protein backbones with polyethylene glycols, such as molecules to create potent medications. Gryphon Therapeutics, Inc. was formerly known as Gryphon Sciences and changed its name in October, 2002. The company was founded in 1993 and is based in South San Francisco, California.
600 Gateway Boulevard
South San Francisco, CA 94080
Founded in 1993
Key Executives for Gryphon Therapeutics, Inc.
Gryphon Therapeutics, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Gryphon Therapeutics, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.